Martek Signs Agreement with Abbott

11/19/2007

COLUMBIA, Md.— Martek Biosciences Corp. entered into a long-term supply agreement with Abbott Nutrition, a producer of infant formula products including the Similac® Advance® brand. Martek will serve as Abbott’s exclusive worldwide supplier of docosahexaenoic acid (DHA) and arachidonic acid (ARA) for all of its infant formula products. Martek added that its blend of DHA and ARA is currently used in more than 95 percent of U.S. infant formulas. “This new agreement affirms the benefits of adding Martek’s DHA and ARA to infant formula,” said Steve Dubin, CEO of Martek (www.MartekBio.com). “With this new arrangement, two-thirds of Martek’s business in the infant formula market is subject to multi-year, sole source agreements.”

Share this article: Email, Slashdot, Digg, Del.icio.us, Yahoo!MyWeb, Windows Live Favorites, Furl
Add this article feed to: RSS, My Yahoo, Newsgator, Bloglines

Sponsored Links	Natural Products INSIDER Announcements